中东和非洲过敏反应治疗市场预测至 2028 年 - COVID-19 影响和按药物类型(肾上腺素、抗组胺药、类固醇、β 激动剂等)、给药途径(口服、肠胃外等)、过敏类型进行的区域分析(食物过敏、药物、昆虫叮咬等)和分销渠道(医院药房、零售等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 143    |    Report Code: TIPRE00023952    |    Category: Life Sciences

Middle East and Africa Anaphylaxis Treatment Market

市场介绍

过敏反应是一种过敏反应,可进一步导致称为过敏性休克的致命疾病。当患者的身体对异物产生反应并产生大量组胺从而引发炎症反应时,就会发生过敏反应。这是一种严重的、危及生命的过敏反应,其症状包括吞咽和呼吸困难、皮肤瘙痒和血压降低。

因此,过敏反应发生率的上升预计将对过敏反应产生巨大的需求未来几年,预计这将进一步推动过敏反应治疗市场。

中东国家的社会经济状况也受到了 COVID-19 大流行的广泛影响。然而,各国对新冠肺炎 (COVID-19) 大流行做出了明智的反应,以避免感染传播。与其他地区类似,实行了封锁和社会疏远,这削弱了这些趋势,阻碍了人们获得工作、正常收入、付款、展会、学校和医疗保健。因此,预计这些国家已经遭受了巨大损失,并且仍在努力挽回损失。由于经济欠发达,大多数国家都依赖医疗器械供应商。此外,COVID-19在非洲和喀麦隆、埃及、阿尔及利亚、摩洛哥、南非、多哥、尼日利亚、塞内加尔和突尼斯等其他低收入国家的传播存在高度不确定性。由于 COVID-19 在非洲广泛爆发,导致医疗服务中断。然而,由于该地区对该地区与病毒感染相关的哮喘和过敏性疾病的治疗认识不断增强,此次大流行中的过敏反应治疗市场正在增长。

 

 

市场概况与动态

<中东和非洲的过敏反应治疗市场预计将从2021年的5220万美元增长到2028年的8710万美元;预计 2021 年至 2028 年复合年增长率为 7.6%。新型药物递送系统支持提高药物效力和控制药物释放,同时提供持续的治疗效果以确保可靠的安全性。许多药物都有一个最大浓度范围才能发挥最大功效,高于或低于浓度可能会有毒或无法产生药用。此外,各种药物递送和药物靶向系统被解释为具有最小化药物降解以及防止有害副作用的能力。当发生过敏反应时,肌内注射肾上腺素通常没有得到充分利用,这主要是由于无法获得或负担不起。药物提供了多种无痛多次剂量的便利,特别是对于儿童,如果需要,可用于过敏反应的院外紧急治疗。

 

< strong>主要细分市场

就药物类型而言,肾上腺素细分市场在2020年中东和非洲过敏反应治疗市场中占据最大份额。从给药途径来看,2020年中东和非洲过敏反应治疗市场中,注射给药细分市场占据最大份额;从过敏类型来看,食物过敏细分市场在中东和非洲过敏反应治疗市场中占据最大份额2020年,从分销渠道来看,零售药店在2020年过敏反应治疗市场中占有较大的市场份额。

 

< /p>

主要来源和上市公司

准备本过敏反应治疗市场报告时提到的一些主要一手和二手来源中东和非洲的网站包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Amneal Pharmaceuticals Inc.、Mylan NV、Abbott、Pfizer Inc.、Glaxosmithkline Plc.、Merck and Co., Inc.、Teva Pharmaceutical Industries Ltd. 和 ALK-ABELLó。

< p>

 

购买报告的理由

  • 了解中东和非洲过敏反应治疗市场格局并确定最有可能的细分市场确保强劲回报
  • 了解中东和非洲过敏反应治疗市场不断变化的竞争格局,保持领先地位
  • 有效规划中东地区的并购和合作交易通过识别最有希望销售的细分市场,东非过敏反应治疗市场
  • 通过对中东和非洲过敏反应治疗市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • li>
  • 获取中东和非洲地区2021-2028年各细分市场的市场收入预测

 

中东和非洲过敏症治疗市场细分

药物类型

  • 肾上腺素
  • 抗组胺药
  • 类固醇
  • β-激动剂
  • 其他

 

给药途径

  • 肠胃外
  • 口服
  • 其他

 

按过敏类型

  • 食物过敏
  • 药物
  • < span>昆虫叮咬
  • 其他

 

按分销渠道

  • 医院药房
  • 零售药房
  • < li>其他

 

按国家/地区

  • < span>中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区

 

 

提及的公司

  1. Amneal Pharmaceuticals Inc.
  2. Mylan NV
  3. 雅培
  4. 辉瑞公司
  5. 葛兰素史克公司
  6. 默克公司
  7. < li>梯瓦制药工业有限公司       
  8. ALK-ABELLó   

 

 

Middle East and Africa Anaphylaxis Treatment Strategic Insights

Strategic insights for Middle East and Africa Anaphylaxis Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-anaphylaxis-treatment-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Anaphylaxis Treatment Report Scope

Report Attribute Details
Market size in 2021 US$ 52.2 Million
Market Size by 2028 US$ 87.1 Million
Global CAGR (2021 - 2028) 7.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 药物类型
  • 肾上腺素
  • 抗组胺药
  • 类固醇
  • β-激动剂
By 给药途径
  • 口服
  • 肠胃外
By 过敏类型
  • 食物过敏
  • 药物过敏
  • 昆虫叮咬
By 分销渠道
  • 医院药房
  • 零售
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Amneal Pharmaceuticals Inc.
  • Mylan N.V.
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-ABELLó
  • Get more information on this report

    Middle East and Africa Anaphylaxis Treatment Regional Insights

    The regional scope of Middle East and Africa Anaphylaxis Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-anaphylaxis-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa Anaphylaxis Treatment Market

    1. Amneal Pharmaceuticals Inc.
    2. Mylan N.V.
    3. Abbott
    4. Pfizer Inc.
    5. Glaxosmithkline Plc.,
    6. Merck And Co., Inc.
    7. Teva Pharmaceutical Industries Ltd.        
    8. ALK-ABELLó   
    Frequently Asked Questions
    How big is the Middle East and Africa Anaphylaxis Treatment Market?

    The Middle East and Africa Anaphylaxis Treatment Market is valued at US$ 52.2 Million in 2021, it is projected to reach US$ 87.1 Million by 2028.

    What is the CAGR for Middle East and Africa Anaphylaxis Treatment Market by (2021 - 2028)?

    As per our report Middle East and Africa Anaphylaxis Treatment Market, the market size is valued at US$ 52.2 Million in 2021, projecting it to reach US$ 87.1 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Anaphylaxis Treatment Market report typically cover these key segments-

  • 药物类型 (肾上腺素, 抗组胺药, 类固醇, β-激动剂)
  • 给药途径 (口服, 肠胃外)
  • 过敏类型 (食物过敏, 药物过敏, 昆虫叮咬)
  • What is the historic period, base year, and forecast period taken for Middle East and Africa Anaphylaxis Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Anaphylaxis Treatment Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Anaphylaxis Treatment Market?

    The Middle East and Africa Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Amneal Pharmaceuticals Inc.
  • Mylan N.V.
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-ABELLó
  • Who should buy this report?

    The Middle East and Africa Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.